Advanced pancreatic adenocarcinoma: a review of current treatment strategies and developing therapies.
- Published in:
- Therapeutic Advances in Medical Oncology, 2015, v. 7, n. 2, p. 68, doi. 10.1177/1758834014564775
- By:
- Publication type:
- Article
Works matching IS 17588340 AND DT 2015 AND VI 7 AND IP 2
Results: 7
1
2
Does metabolic syndrome or its components associate with prostate cancer when diagnosed on biopsy?
- Published in:
- Therapeutic Advances in Medical Oncology, 2015, v. 7, n. 2, p. 63, doi. 10.1177/1758834014560158
- By:
- Publication type:
- Article
3
Anaplastic lymphoma kinase (ALK) gene alteration in signet ring cell carcinoma of the gastrointestinal tract.
- Published in:
- Therapeutic Advances in Medical Oncology, 2015, v. 7, n. 2, p. 56, doi. 10.1177/1758834014567117
- By:
- Publication type:
- Article
4
Blinded by the light: why the treatment of metastatic melanoma has created a new paradigm for the management of cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2015, v. 7, n. 2, p. 107, doi. 10.1177/1758834014566619
- By:
- Publication type:
- Article
5
Management of BRAF and MEK inhibitor toxicities in patients with metastatic melanoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2015, v. 7, n. 2, p. 122, doi. 10.1177/1758834014566428
- By:
- Publication type:
- Article
6
Nivolumab in NSCLC: latest evidence and clinical potential.
- Published in:
- Therapeutic Advances in Medical Oncology, 2015, v. 7, n. 2, p. 85, doi. 10.1177/1758834014567470
- By:
- Publication type:
- Article
7
Nivolumab in melanoma: latest evidence and clinical potential.
- Published in:
- Therapeutic Advances in Medical Oncology, 2015, v. 7, n. 2, p. 97, doi. 10.1177/1758834014567469
- By:
- Publication type:
- Article